Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAS-trace: Observational RAS Monitoring in RAS/BRAF Wild-type Advanced Colorectal Cancer Treated With Anti-EGFR Antibodies
jRCT1050210160Active, not recruiting
- Sponsor
- Hyogo Medical University
- Start
- Jan 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial in colorectal cancer (CRC), sponsored by Hyogo Medical University. Primary endpoint: Time to RAS mutations acquired. Started Jan 2022; status: active, not recruiting.
02
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCT1050210160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1050210160.